Mankind Pharma Sees Significant Surge in Open Interest Amid Increased Trading Activity
Mankind Pharma Ltd has seen a notable increase in open interest, reaching 17,492 contracts, alongside a trading volume of 44,243 contracts, indicating heightened market activity. The stock has shown resilience, trading above key moving averages and achieving a significant rise in delivery volume, reflecting strong engagement in the market.
Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 17,492 contracts, reflecting a rise of 2,395 contracts or 15.86% from the previous open interest of 15,097. This uptick in open interest coincides with a trading volume of 44,243 contracts, indicating heightened activity in the derivatives market.In terms of price performance, Mankind Pharma has shown resilience, gaining 5.29% over the past four days, despite underperforming its sector by 0.25% today. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price trajectory. Additionally, the stock's delivery volume reached 5.8 lakh on August 21, marking a substantial increase of 70.89% compared to the 5-day average delivery volume.
With a market capitalization of Rs 1,08,238 crore, Mankind Pharma continues to maintain a liquid trading environment, suitable for transactions of up to Rs 3.71 crore based on 2% of the 5-day average traded value. Overall, the notable rise in open interest and consistent trading performance underscores the stock's active engagement in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
